GTx-Onco™ is a state-of-the-art precision oncology platform designed to transform tumor DNA and RNA sequencing data into clinically actionable insights. It detects key mutations, gene fusions, and other genomic alterations that drive cancer progression, providing a comprehensive view of the tumor’s molecular landscape.
The platform empowers personalized treatment decisions through evidence-based therapy recommendations, including off-label drug options and metabolism-informed dietary guidance. By integrating advanced analytics with clinical expertise, GTx-Onco™ enables smarter, more targeted cancer care—supporting clinicians and patients in the pursuit of truly individualized outcomes.
Get Expert Support for Precision Oncology Testing
Whether you're a clinician seeking evidence-based recommendations, or a healthcare provider exploring genomic profiling for your patients, our team is here to help.
*All information is handled with strict confidentiality.
Bioinformatique